Person profile
Public information reviewedJoshua Kazam
Board role
Director · Allogene Therapeutics, Inc. (NASDAQ: ALLO)
Allogene Therapeutics, Inc. (NASDAQ: ALLO)
Director · Current mandate
Director
- Evidence records
- 3
- Profile ownership
- Not yet claimed
- Record reviewed
- May 15, 2026

